Emrah Yatkin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Multidrug Resistant

Magnetic Resonance

Top Venues

Laboratory animals

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tero Satomaa, Henna Pynnönen, Olli Aitio, Jukka O Hiltunen, Virve Pitkänen, Tuula Lähteenmäki, Titta Kotiranta, Annamari Heiskanen, Anna-Liisa Hänninen, Ritva Niemelä, Jari Helin, Heikki Kuusanmäki, Ida Vänttinen, Ramji Rathod, Anni I Nieminen, Emrah Yatkin, Caroline A Heckman, Mika Kontro, Juhani Saarinen
Targeting CD33+ acute myeloid leukemia with GLK-33, a lintuzumab-auristatin conjugate with a wide therapeutic window. Molecular cancer therapeutics (2024)
Tero Satomaa, Henna Pynnönen, Olli Aitio, Jukka O Hiltunen, Virve Pitkänen, Tuula Lähteenmäki, Titta Kotiranta, Annamari Heiskanen, Anna-Liisa Hänninen, Ritva Niemelä, Jari Helin, Heikki Kuusanmäki, Ida Vänttinen, Ramji Rathod, Anni I Nieminen, Emrah Yatkin, Caroline A Heckman, Mika Kontro, Juhani Saarinen
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic Window. Molecular cancer therapeutics 23 (8) (2024)
Çiğdem Haser, Sevcan Hakyemez-Paul, Ella Kujala, Paulina Chrusciel, Varpu Laine, Emrah Yatkin
Students' experiences of blended laboratory animal science courses. Laboratory animals (2021)
Emrah Yatkin, Nina Kulmala, Aija Saukkonen, Jukka Maaranen, Ulla-Marjut Jaakkola
A real-time health notification system aimed at enhancing the interaction between animal care staff and researchers promotes animal welfare. Laboratory animals 55 (3) (2021)